Psychiatry
Cohort Study | Association between antiepileptic drugs and incident Parkinson disease
3 Feb, 2023 | 13:51h | UTCAssociation Between Antiepileptic Drugs and Incident Parkinson Disease in the UK Biobank – JAMA Neurology (link to abstract – $ for full-text)
Commentary on Twitter
This study using @uk_biobank data found evidence of an association between anti-epileptic drugs and incident #ParkinsonDisease. https://t.co/58PMlWQUYU
— JAMA Neurology (@JAMANeuro) December 28, 2022
M-A | Depressive symptoms in individuals with persistent postconcussion symptoms
3 Feb, 2023 | 13:48h | UTCCommentary: Significant Link Seen for Persistent Postconcussion Symptoms, Depression – HealthDay
Commentary on Twitter
Patients with persistent postconcussion symptoms are at increased risk of experiencing symptoms of depression. Post-injury support and interventions targeting mental health are necessary for optimal outcomes. https://t.co/7KiletIsf6
— JAMA Network Open (@JAMANetworkOpen) December 27, 2022
Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews
2 Feb, 2023 | 15:05h | UTCEditorial: Rethinking use of medicines for chronic pain – The BMJ
News Release: Antidepressants use for chronic pain on the rise, but are they effective? – University of Sidney
Commentary from the author on Twitter (thread – click for more)
Out today in @bmj_latest
We reviewed the evidence on the efficacy of antidepressants for pain in adults
We showed that antidepressants are effective for some pain conditions, but for most they are either ineffective or evidence is inconclusivehttps://t.co/E2XVQ9oGUQ
🧵 pic.twitter.com/kBo7eAyeCP— Giovanni Ferreira (@giovanni_ef) February 1, 2023
Cohort Study | Association of treatment-resistant depression with patient outcomes and health care resource utilization
2 Feb, 2023 | 14:47h | UTCNews Release: Patients with treatment resistant depression at higher risk of early death – Karolinska Institutet
Commentaries:
Treatment-Resistant Depression Common and Costly – HealthDay
Phase 2 RCT | Lysergic acid diethylamide–assisted therapy in patients with anxiety with and without a life-threatening illness
2 Feb, 2023 | 14:45h | UTC
Placebo and nocebo effects: from observation to harnessing and clinical application
2 Feb, 2023 | 14:38h | UTC
Cohort Study | Associations between infant screen use, electroencephalography markers, and cognitive outcomes
1 Feb, 2023 | 13:34h | UTCCommentaries:
Infant Screen Use Linked to Alterations in Cortical EEG Before Age 2 – HealthDay
Your child’s academic success may start with their screen time as infants, study says – CNN
Review | Safety and effectiveness of NMDA receptor antagonists for depression
1 Feb, 2023 | 13:05h | UTC
A new study provides insights into the emotional ‘blunting’ caused by common antidepressants
30 Jan, 2023 | 01:05h | UTCNews Release: Scientists explain emotional ‘blunting’ caused by common antidepressants – University of Cambridge
Commentary from the authors: Emotional ‘blunting’ and antidepressants – new research suggests why this is happening – The Conversation
Commentary on Twitter
One of our top rated articles on @altmetric this week was published in @npp_journal. Read 'Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study' here: https://t.co/4W8XGoyYMn pic.twitter.com/C1XKcglGtW
— Springer Nature (@SpringerNature) January 27, 2023
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
26 Jan, 2023 | 12:55h | UTC
Cohort Study | Alcohol-related problems before and after metabolic and bariatric surgery in adolescents
26 Jan, 2023 | 12:01h | UTCA Prospective Cohort of Alcohol use and Alcohol-related Problems Before and After Metabolic and Bariatric Surgery in Adolescents – Annals of Surgery (link to abstract – $ for full-text)
News Release: Problems with Alcohol Increase After Weight-Loss Surgery in Adolescence – Ann & Robert H. Lurie Children’s Hospital of Chicago
Related Study: Association Between Bariatric Surgery and Alcohol Use–Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort – JAMA Surgery (link to abstract – $ for full-text)
ACP Guideline | Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder
24 Jan, 2023 | 14:41h | UTCSee also:
Cohort Study | The temporal relationship between severe mental illness diagnosis and chronic physical comorbidity
24 Jan, 2023 | 14:31h | UTCCommentary: Severe mental illness and comorbid chronic physical illness: the clock’s ticking – The Mental Elf
Commentary on Twitter
"Elevated odds of multiple conditions at the point of severe mental illness diagnosis suggest that early intervention on physical health parameters is necessary to reduce morbidity and premature mortality."
New research Article @NaomiLaunders @J_F_Hayes https://t.co/Th4b4IPV1l
— The Lancet Psychiatry (@TheLancetPsych) July 25, 2022
M-A | Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics
24 Jan, 2023 | 14:23h | UTCCommentary: Metabolic Side Effects of Antipsychotics Vary, Meta-Analysis Finds – Psychiatric News Alert
Cohort Study | Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis
24 Jan, 2023 | 14:14h | UTC
RCT | Telehealth treatment of behavior problems in young children with developmental delay
20 Jan, 2023 | 14:38h | UTCTelehealth Treatment of Behavior Problems in Young Children With Developmental Delay: A Randomized Clinical Trial – JAMA Pediatrics (link to abstract – $ for full-text)
Commentaries:
Telehealth Parent-Child Interaction Therapy Aids Child Behavior – HealthDay
Commentary on Twitter
Study provides evidence that a #telehealth-delivered parenting intervention with real-time therapist coaching led to significant and maintained improvements for young children with #DevelopmentalDelay and their caregivers. https://t.co/xYOOxDfL4U
— JAMA Pediatrics (@JAMAPediatrics) January 10, 2023
Review | An FP’s guide to identifying—and treating—postpartum depression
19 Jan, 2023 | 13:56h | UTCAn FP’s guide to identifying—and treating—postpartum depression – Journal of Family Practice
Cohort Study | Safety and effects of buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
18 Jan, 2023 | 14:10h | UTCCommentary: Buprenorphine-Naloxone Appears Safe for Maternal Opioid Use Disorder – HealthDay
State of the Art Review | Telemental health for clinical assessment and treatment
17 Jan, 2023 | 13:29h | UTCTelemental health for clinical assessment and treatment – The BMJ
Commentary on Twitter
Telemental health use increased substantially and globally during the pandemic, however, the prevalence of its use has varied widely.
What do we know about the efficacy of telemental health for treatment and what do guidelines say on best practice?https://t.co/AqHKMkKNIV
— The BMJ (@bmj_latest) January 16, 2023
RCT | Effects of breathwork exercises vs. mindfulness meditation in mood and anxiety
17 Jan, 2023 | 13:25h | UTCCommentaries:
A Simple, 5-Minute Breathing Technique Is a Powerful Tool to Reduce Anxiety – Science Alert
Commentary on Twitter
New paper @CellRepMed comparing effects of brief (5min) meditation vs brief deliberate breathing practices.
Basically: Breathwork > Meditation for improving mood & autonomic physiology around the clock & Physiological Sighs provide maximal stress relief. https://t.co/sYe3N7RJT5— Andrew D. Huberman, Ph.D. (@hubermanlab) January 10, 2023
M-A | Effect of breathwork on stress and mental health
15 Jan, 2023 | 20:28h | UTC
Commentary on Twitter
A meta-analysis in @SciReports shows that breathwork may be effective for improving stress and mental health. The authors also call for nuanced research approaches with low risk-of-bias study designs to avoid a miscalibration between hype and evidence. https://t.co/iTLGE2AsPT pic.twitter.com/SM5FBL2idK
— Nature Portfolio (@NaturePortfolio) January 12, 2023
Cohort Study | Trends in antipsychotic prescribing to children and adolescents in England
15 Jan, 2023 | 20:26h | UTCNews Release: Researchers reveal worrying rise in antipsychotic prescriptions for children and young people – University of Manchester
Commentary on Twitter
"From 2000 to 2019, the prescriptions for antipsychotics for children and adolescents in England doubled from an annual period prevalence in 2000 of 0·057% (95% CI 0·052–0·063%) to 0·105% (0·100–0·111%) in 2019"
New research Article @FBMH_UoM @GMMH_NHS https://t.co/ukXkSVfhtI
— The Lancet Psychiatry (@TheLancetPsych) January 11, 2023
SR | Baclofen for alcohol use disorder
15 Jan, 2023 | 20:11h | UTCBaclofen for alcohol use disorder – Cochrane Library
Summary: Baclofen for alcohol use disorder – Cochrane Library
RCT | Ecopipam for Tourette Syndrome
15 Jan, 2023 | 20:09h | UTCEcopipam for Tourette Syndrome: A Randomized Trial – Pediatrics
Commentary: Ecopipam May Reduce Tics in Children With Tourette Syndrome – Psychiatric News Alert
Commentary on Twitter
Ecopipam, a selective D1-like receptor antagonist, is in development for children & adolescents with Tourette syndrome. Can ecopipam achieve a clinically meaningful reduction in tics without the disadvantages of D2-like receptor antagonists? https://t.co/GXxnPsP74C #Pediatrics pic.twitter.com/14fwu4npJi
— AAP Pediatrics (@aap_peds) January 11, 2023
Retrospective Study | Most patients with long Covid developed after mild infection get better within a year
13 Jan, 2023 | 13:42h | UTCLong covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study – The BMJ
News Release: Most long COVID effects resolve within a year after mild infection, finds study- British Medical Journal
Commentary: Long COVID After Mild Infection? It Fades Within a Year – HealthDay